# NATCO Pharma Launches Carboplatin in US Market

> NATCO Pharma USA partners with Teyro Labs to launch generic Carboplatin injection in US to address drug shortages.
- Title: NATCO Pharma Launches Carboplatin in US Market | Shortify
- Summary: NATCO Pharma USA partners with Teyro Labs to launch generic Carboplatin injection in US to address drug shortages. NATCO Pharma USA launched Carboplatin…
- Keywords: carboplatin injection, natco pharma, paraplatin, drug shortages, us pharmaceutical market, teyro labs pvt ltd, generic drug launch, advanced ovarian carcinoma, NATCO, Pharma, Launches, Carboplatin
- Source: The Economic Times — https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-subsidiary-launches-carboplatin-in-us-market-to-address-shortages/articleshow/135044938.cms
- Author: ET Online
- Published: 2026-10-19T09:27:00+00:00
- Read time: 1 min
- Topics: carboplatin injection, natco pharma, paraplatin, drug shortages, us pharmaceutical market, teyro labs pvt ltd, generic drug launch, advanced ovarian carcinoma
## NATCO Pharma USA Launch
NATCO Pharma USA announced the launch of Carboplatin Injection, a generic version of Paraplatin, in the US market.
## Collaboration with Teyro Labs
The US subsidiary partners with Chennai-based Indian pharmaceutical company Teyro Labs Pvt Ltd for manufacturing.
## Addressing Drug Shortages
The launch aims to address critical shortages of Carboplatin injection in the US market for advanced ovarian carcinoma treatment.
## Key takeaway

NATCO Pharma USA launched Carboplatin injection in US market with Teyro Labs to address critical drug shortages.